US House Committee Requests Proof Of FDA Progress Seizing Opioids In International Mail
This article was originally published in The Pink Sheet
Energy & Commerce's Republican and Democrat leadership ask FDA Commissioner Scott Gottlieb about work by the agency's Office of Criminal Investigations focused on opioid drugs, the office's staffing and its priorities. They note FDA's FY2018 appropriation included $94m for its work in international mail facilities.
You may also be interested in...
Across all 9 IMF facilities in FY 2019, FDA screened around 25,200 parcels containing more than 41,000 products, detained more than 38,000 including 1,801 identified as supplements and expects to destroy more than 17,000.
In four days before Scott Gottlieb's stint as commissioner ended, FDA announced official start of initiative to consider regulatory pathways to make CBD compliant as a dietary ingredient, launched another shot across kratom sector's bow and noted more examples of e-cigarette marketers crossing regulatory lines.
Between start of federal government partial shutdown on Dec. 22 and federal agencies' re-opening on Jan. 28, FDA Customs and Border Protection officials examining international mail shipments found ED drugs in six products and two weight loss ingredients approved in the US in four.